BioCentury | Sep 20, 2018
Distillery Therapeutics

Neurology; ophthalmic disease

...mouse models of PD. TARGET/MARKER/PATHWAY: Inositol 1,4,5-triphosphate receptors (ITPR; IP3R); voltage-dependent anion channel 1 (VDAC1); mitochondrial calcium uniporter (MCU)...
...CONTACT: Bingwei Lu, Stanford University, Stanford, Calif. email: bingwei@stanford.edu Jaime De Leon Stanford University Inositol 1,4,5-triphosphate receptors (ITPR) (IP3R) Mitochondrial calcium uniporter (MCU) Mitochondrial...
BioCentury | Apr 4, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: March 2018

...inhibiting EDC4 could help treat cervical cancer. Autonomous University of Barcelona Distillery Therapeutics Colorectal cancer Mitochondrial calcium uniporter (MCU)...
BioCentury | Mar 22, 2018
Distillery Therapeutics

Cancer

...to treat Alzheimer’s disease and amyotrophic lateral sclerosis. TARGET/MARKER/PATHWAY: Receptor-interacting serine-threonine kinase 1 (RIPK1; RIP1); mitochondrial calcium uniporter (MCU)...
...CONTACT: Jianqiang Cai, Peking Union Medical College, Beijing, China email: caijianqiang188@sina.com Sandi Wong Peking Union Medical College Peking University Mitochondrial calcium uniporter (MCU) Receptor-interacting...
Items per page:
1 - 3 of 3